1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Why is this company still on CP?

Discussion in 'Genta' started by Anonymous, Feb 19, 2011 at 8:25 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    ???
     
  2. Anonymous

    Anonymous Guest

    Well there is 3 of us in the home office and we are working night and day and even weekends. Don't worry about it!
     
  3. Anonymous

    Anonymous Guest

    "There is 3 of us"? Wow. I see one of you did not make it into English 101. So, really only two...
     
  4. Anonymous

    Anonymous Guest

    Two and a half men
     
  5. Anonymous

    Anonymous Guest

    Lloyd, have you no shame?
     
  6. Anonymous

    Anonymous Guest

    We getting ready for a launch this fall for a new cough and cold capsule that is better and more effective than anything out there.
     
  7. Anonymous

    Anonymous Guest

    TEST